维普中文期刊产品整合服务
19篇 您的检索式:作者名="SCARR E"
    题名 作者 年代 出处 被引量
1Gene expression profiling in Brodmann's area 46 from subjects with schizophrenia显示文摘Dean B Keriakous D Scarr E 2007Aust N Z J Psychiatry2007,41,4:1
2The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: An autoradiography study 显示文摘Chavez C Hollaus M Scarr E 2010Brain Research2010,1321,19:1
3Regionally specific changes in levels of cortical S100 beta in bipolar 1 disorder but not schizophrenia 显示文摘Gray Land Scarr E 2006Australian & New Zealand Journal of Psychiatr2006,40,3:1
4Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia显示文摘Dean B Gray L Scarr E 2006Aust N Z J Psychiatry2006,40,3:1
5Differential changes in apolipoprotein E in schizophrenia and bipolar Ⅰ disorder显示文摘Digney A Keriakous D Scarr E 2005Biol Psychiatry2005,57,7:1
6Antipsychotic drugs:evolving mechanisms of action with improved therapeutic benefits 显示文摘DEAN B SCARR E 2004Curr Drug Targets CNS Neurol Disord2004,3,3:1
7Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia显示文摘Scarr E Cowie TF Kanellakis S 2009Mol Psychiatry2009,14,11:1
8Decreased cortical muscarinic Ml receptors in schizophrenia are associated with changes in gene promoter raethylation,mRNA and gene targeting microRNA 显示文摘Scarr E Craig JM Cairns MJ 2013Transl Psychiatry2013,19,3:1
9Cortical glutamatergic markers in schizophrenia 显示文摘SCARR E BENEYTO M MEADORWOODRUFF J H 2005Neuropsychopharmacology2005,30,:1
10Antipsychotic drugs:evolving mechanisms of action with improved therapeutic benefits显示文摘DEAN B SCARR E 2004Curr Drug Targets CNS Neurol Disord2004,3,3:1
11Cholinergic muscarinic rn4 receptor gene polymorphisms , a potential risk factor and pharmacogenomic marker for schizophrenia显示文摘Scarr E Urn JY Cowie TF 2013Schizophr Res2013,146,13:1
12The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain:an autoradiography study显示文摘Chavez C Hollaus M Scarr E 0,,:1
13Muscarinic receptors: their roles in disorders of the central nervous system and potential as therapeutic targets显示文摘Scarr E 2012CNS Neurosci Ther2012,18,5:1
14Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia显示文摘Dean B Gray L Scarr E 2006Aust N Z J Psychiatry2006,40,3:1
15Antipsychotic drugs:evolving mechanisms of action with improved therapeutic benefits显示文摘Dean B Scarr E 0,,03:1
16Antipsychotic drugs:evolving mechanisms of action with improved therapeutic benefits显示文摘DEAN B SCARR E 2004Curr Drug Targets CNS Neurol Disord2004,3,3:1
17Antipsychotic drugs: evolving mechanisms of action with improved therapeutic benefits 显示文摘DEAN B SCARR E 2004Curr Drug Targets CNS Neurol Disord2004,3,3:1
18GSK-3 parameters in postmortem frontal cortex and hippocampus of schizo- phrenic patients 显示文摘Nadri C Dean B Scarr E 2004Schizophr Res2004,71,23:1
19Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder显示文摘Scarr E Gray L Keriakous D 2006Bipolar Disord2006,8,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费